Equity Crowdfunding

Beacon is a company that offers software and supporting services to help a client optimise their digital marketing efforts and improve their marketing Return-on-Investment (ROI). The company offers clients services like campaign management, PPC (Pay Per Click) campaign analytics, social media analytics, and anti-fraudulent click system etc. Using the company's portal, marketers can compare costs and revenue across all digital channels, channel by channel, and with their off-line marketing efforts. Beacon aims at removing ‘non-human clicks’ and giving direct independent attribution of emails, posts, ad’s, etc. to specific website actions and business goals thereby improving engagement and reducing costs. According to Stratistics Market Research Consulting, the web analytics tools market is expected to reach $4.9 billion by 2022, growing at a Compound Annual Growth Rate (CAGR) of 20.8%, in which, Beacon aims to be a leading contender. The company will use the investment to grow its business across different verticals.

Evolution Biotechnologies (EB) is a company that aims to bring technologies of biological control from their proven uses in agriculture into high-need and high-value biomedical markets. The company aims to curtail the spread of the house dust mite, a key cause of asthma, through its patented device. Its room treatment kit for domestic or commercial use contains natural agents that target the house dust mite in a highly specific way. The company anticipates that this method will be able to exert widespread, stable control across a whole room from limited initial applications, following a standard agricultural practice. EB expects a potential market size of $2 billion per annum in China, the UK, Europe, and the United States for its product. It is seeking an investment of £2 million to bring the aforementioned product to field trials.